Aksìa Group SGR has sold Lameplast to Tekni-Plex
Aksìa Group, the Italian mid-market private equity firm, has completed the sale of Lameplast S.p.A., the leading producer of pharmaceutical packaging solutions and medical devices, to Tekni-Plex, global manufacturer of packaging and tubing products for the food and beverage, healthcare and personal care markets, for a total consideration of Euro 88 million.
Paul Young, President and CEO at Tekni-Plex, commented, “Lameplast brings Tekni-Plex specific expertise in packaging that was not part of our portfolio previously. We will now be able to offer a rigid packaging solution for prescription and over-the-counter medications and vaccines. These products are one more way we can provide value to healthcare and cosmetic companies around the world.”
Lincoln International acted as the exclusive M&A adviser to Aksìa Group and other shareholders in this transaction, supporting the sellers in all aspects of the deal.
Headquartered in Italy, Lameplast has more than 40 years of experience providing packaging solutions to blue chip Italian and international healthcare companies. The company has earned a reputation for its single and multi-dose drug delivery containers, as well as its filling and sealing machines. Lameplast has been awarded numerous international patents for its innovative packaging solutions.
About Aksìa Group
Aksìa Group is a leading Italian private equity fund operating out of Milan. Aksìa Group focuses on sectors where Italy boasts a highly developed tradition of specialization and international leadership, and stands out for its expertise in situations involving companies’ organizational structure, core characteristics and market position internationalization, as well as in generational changeover, management buy-outs and technological innovation.
Tekni-Plex is a U.S.-based company focused on developing and manufacturing innovative packaging materials, medical compounds and precision-crafted medical tubing solutions for some of the most well-known names in the medical, pharmaceutical, personal care, household & industrial and food & beverage markets.
Lincoln’s extensive expertise in the packaging business, combined with their tailored approach, resulted in a highly focused and dedicated process which was pivotal in attracting multiple strategic buyers and maximize our value creation.
Meet our Senior Team
View More Transactions in Healthcare
UAS Laboratories has entered into an agreement to be acquired by Chr. Hansen Holding A/S
Lincoln International advised Gruppo Sapio on the acquisition of a majority stake in Homeperf from Parquest Capital; BNP Paribas Développement and Arkea Capital will reinvest in the business alongside Sapio
Lincoln International is pleased to announce that it has advised IntegriChain, Inc. on the acquisition of the life sciences division of Cumberland
Lincoln International is pleased to announce the sale of substantially all of the operating assets of Valeritas Holdings, Inc. (NASDAQ:VLRX) pursuant to Section 363 of the U.S. Bankruptcy Code to Zealand Pharma A/S (NASDAQ:ZEAL)